US FDA approves Cuvposa oral solution for chronic drooling in kids - International

Links shared publicly online about this topic.

  • 985
    total visits

US FDA approves Cuvposa oral solution for chronic drooling in kids - International

pharmabiz.com

The US Food and Drug Administration approved Cuvposa (glycopyrrolate) oral solution to treat chronic severe drooling caused by neurologic disorders in children ages three years to 16 years.

View full resource at pharmabiz.com

Tags: Neurology, Disease and Condition, Drug, Children's Health, FDA

  • Share

Most Recently Shared on July 30, 2010 at 11:39 am By:

OralHealth_OW Oral Health OW

US FDA approves Cuvposa oral solution for chronic drooling in kids: The US Food and Drug Administration approved C... http://bit.ly/bXhGLf

2 years ago...

Shionogi launches CUVPOSA for pediatric chronic severe drooling

news-medical.net — “Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. commercial availability of CUVPOSA™ (glycopyrrolate) oral solution, the first and only FDA-approved treatment to reduce chronic severe drooling in patients aged 3 to 16 with neurologic conditions associated with problem drooling, such as cerebral palsy.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on April 7, 2011 at 2:09 pm By:

NewsMedical News-Medical.Net Health News

Shionogi launches CUVPOSA for pediatric chronic severe drooling: Shionogi Inc., the U.S.-based group company of ... http://bit.ly/gMBd6q

1 year ago...

FDA Approves Drug For Chronic Drooling In Children

medicalnewstoday.com — “The U.S. Food and Drug Administration approved Cuvposa (glycopyrrolate) Oral Solution to treat chronic severe drooling caused by neurologic disorders in children ages 3 years to 16 years.View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on July 29, 2010 at 3:07 pm By:

FDA approves Cuvposa Oral Solution for chronic severe drooling in children

news-medical.net — “The U.S. Food and Drug Administration today approved Cuvposa (glycopyrrolate) Oral Solution to treat chronic severe drooling caused by neurologic disorders in children ages 3 years to 16 years.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on July 29, 2010 at 6:01 am By:

NewsMedical News-Medical.Net Health News

FDA approves Cuvposa Oral Solution for chronic severe drooling in children: The U.S. Food and Drug Administration ... http://bit.ly/cogyuk

2 years ago...

Advertisement